Cases journal · 2009
Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Makdsi Fadi, Deversa Roger
Аннотация
INTRODUCTION: Carboplatin and docetaxel are chemotherapy agents that are used to treat some malignancies. This combination has not been documented to date to cause an inflammation of a preexisting actinic keratosis. One previous report has described inflammation of AK lesions after the use of docetaxel alone.
CASE PRESENTATION: We report a case of a 54-year-old male with a history of untreated actinic keratosis and lung cancer. He developed a rash on the sun exposed areas of skin after he received carboplatin and docetaxel. Topical high-potency corticosteroid administration resulted in diminished rash despite the ongoing chemotherapy regimen.
CONCLUSION: We present this case to emphasis this potential reaction in predisposed individuals after using the combination of carboplatin and docetaxel, and to help physicians making the appropriate decision whether to continue the chemotherapy or discontinued it.
CASE PRESENTATION: We report a case of a 54-year-old male with a history of untreated actinic keratosis and lung cancer. He developed a rash on the sun exposed areas of skin after he received carboplatin and docetaxel. Topical high-potency corticosteroid administration resulted in diminished rash despite the ongoing chemotherapy regimen.
CONCLUSION: We present this case to emphasis this potential reaction in predisposed individuals after using the combination of carboplatin and docetaxel, and to help physicians making the appropriate decision whether to continue the chemotherapy or discontinued it.